Skip to main content

Biostage (BSTG) Announces Groundbreaking Data from Cellspan Study with Mayo Clinic

Biostage, Inc. (Nasdaq: BSTG) announced significant, pre-clinical data, including the complete regeneration of a segment of the esophagus, from its collaborative large-animal study of its Cellspanâ„¢ organ implants with Mayo Clinic. Biostage will review this research in a conference call today at 9:00 am ET (details below).

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino